Canada Pharmaceuticals

Knight Therapeutics Inc (GUD)

Track

Track

Knight Therapeutics saw thirteen planned purchases by seven insiders totaling 67,655.70 CAD over ninety days. Despite a recent earnings report missing expectations, the stock price rose 14.9%. These transactions occurred alongside earlier divestments by a director, reflecting varied activity levels within the firm's leadership team as shares trade near their yearly peak.
Ticker: GUD Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Knight Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Utchanah, Arvind Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
250.11
Quantity 63,470 -26.6%
Value CA$153,151
Utchanah, Arvind Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
277.68
Quantity 64,147 -17.9%
Value CA$1,161,135
3.4
Sakhia, Samira Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Planned purchase
Price
292.94
Quantity 14,936 +17.0%
Value CA$3,355,629
3.4
Sakhia, Samira Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Planned purchase
Price
9.36
Quantity 1,934 +0.4%
Value CA$18,102
Lopez, German Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
5.22
Quantity 200 +1.3%
Value CA$1,044
Lopez, German Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
9.36
Quantity 794 +5.5%
Value CA$7,432
2.8
Khouri, Amal Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
5.22
Quantity 593 +0.3%
Value CA$3,095
2.8
Khouri, Amal Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
9.36
Quantity 774 +0.4%
Value CA$7,245
3.7
Goodman, Jonathan Ross Director of Issuer, Director or Senior Officer of 10% Security Holder Non-Executive Director
Transaction date
Planned purchase
Price
5.22
Quantity 267 +0.0%
Value CA$1,394
3.7
Goodman, Jonathan Ross Director of Issuer, Director or Senior Officer of 10% Security Holder Non-Executive Director
Transaction date
Planned purchase
Price
9.36
Quantity 718 +0.1%
Value CA$6,720
Emblem, Susan Caroline Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
5.22
Quantity 361 +0.8%
Value CA$1,884
Emblem, Susan Caroline Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
9.36
Quantity 876 +2.0%
Value CA$8,199
0.5
Dos Santos Dias, Henrique José Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
5.22
Quantity 140 +1.2%
Value CA$731
1.9
Lande, Robert Nathaniel Director of Issuer Non-Executive Director
Transaction date
Sale
Price
8.40
Quantity 20,000 -9.0%
Value CA$168,000
1.9
Lande, Robert Nathaniel Director of Issuer Non-Executive Director
Transaction date
Sale
Price
8.39
Quantity 20,000 -8.2%
Value CA$167,800
0.6
Tremblay, Michael Joseph Director of Issuer Non-Executive Director
Transaction date
Sale
Price
7.58
Quantity 20,000 -90.9%
Value CA$151,600
1.9
Lande, Robert Nathaniel Director of Issuer Non-Executive Director
Transaction date
Sale
Price
7.65
Quantity 20,000 -7.6%
Value CA$153,000
0.6
Zanqueta Coelho Peev, Cristiane Senior Officer of Issuer Officer
Transaction date
Sale
Price
7.09
Quantity 4,938 -33.7%
Value CA$35,010
0.5
Dos Santos Dias, Henrique José Senior Officer of Issuer Officer
Transaction date
Sale
Price
6.54
Quantity 3,867 -24.2%
Value CA$25,290
0.5
Dos Santos Dias, Henrique José Senior Officer of Issuer Officer
Transaction date
Sale
Price
6.54
Quantity 3,816 -19.3%
Value CA$24,957
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-18 2026-06-15 PP Planned purchase
Utchanah, Arvind

Senior Officer of Issuer

Officer
63,470 -26.6%
250.11
CA$153,151 		63,470 -26.6% 250.11 CA$153,151
2026-06-18 2026-06-15 PP Planned purchase
Utchanah, Arvind

Senior Officer of Issuer

Officer
64,147 -17.9%
277.68
CA$1,161,135 		64,147 -17.9% 277.68 CA$1,161,135
2026-06-18 2026-06-15 PP Planned purchase
3.4
Sakhia, Samira

Director of Issuer, Senior Officer of Issuer

Executive Director
14,936 +17.0%
292.94
CA$3,355,629 		14,936 +17.0% 292.94 CA$3,355,629
2026-06-18 2026-06-15 PP Planned purchase
3.4
Sakhia, Samira

Director of Issuer, Senior Officer of Issuer

Executive Director
1,934 +0.4%
9.36
CA$18,102 		1,934 +0.4% 9.36 CA$18,102
2026-06-18 2026-06-15 PP Planned purchase
Lopez, German

Senior Officer of Issuer

Officer
200 +1.3%
5.22
CA$1,044 		200 +1.3% 5.22 CA$1,044
2026-06-18 2026-06-15 PP Planned purchase
Lopez, German

Senior Officer of Issuer

Officer
794 +5.5%
9.36
CA$7,432 		794 +5.5% 9.36 CA$7,432
2026-06-18 2026-06-15 PP Planned purchase
2.8
Khouri, Amal

Senior Officer of Issuer

Officer
593 +0.3%
5.22
CA$3,095 		593 +0.3% 5.22 CA$3,095
2026-06-18 2026-06-15 PP Planned purchase
2.8
Khouri, Amal

Senior Officer of Issuer

Officer
774 +0.4%
9.36
CA$7,245 		774 +0.4% 9.36 CA$7,245
2026-06-18 2026-06-15 PP Planned purchase
3.7
Goodman, Jonathan Ross

Director of Issuer, Director or Senior Officer of 10% Security Holder

Non-Executive Director
267 +0.0%
5.22
CA$1,394 		267 +0.0% 5.22 CA$1,394
2026-06-18 2026-06-15 PP Planned purchase
3.7
Goodman, Jonathan Ross

Director of Issuer, Director or Senior Officer of 10% Security Holder

Non-Executive Director
718 +0.1%
9.36
CA$6,720 		718 +0.1% 9.36 CA$6,720
2026-06-18 2026-06-15 PP Planned purchase
Emblem, Susan Caroline

Senior Officer of Issuer

Officer
361 +0.8%
5.22
CA$1,884 		361 +0.8% 5.22 CA$1,884
2026-06-18 2026-06-15 PP Planned purchase
Emblem, Susan Caroline

Senior Officer of Issuer

Officer
876 +2.0%
9.36
CA$8,199 		876 +2.0% 9.36 CA$8,199
2026-06-18 2026-06-15 PP Planned purchase
0.5
Dos Santos Dias, Henrique José

Senior Officer of Issuer

Officer
140 +1.2%
5.22
CA$731 		140 +1.2% 5.22 CA$731
2026-05-14 2026-05-14 S Sale
1.9
Lande, Robert Nathaniel

Director of Issuer

Non-Executive Director
20,000 -9.0%
8.40
CA$168,000 		20,000 -9.0% 8.40 CA$168,000
2026-05-14 2026-05-14 S Sale
1.9
Lande, Robert Nathaniel

Director of Issuer

Non-Executive Director
20,000 -8.2%
8.39
CA$167,800 		20,000 -8.2% 8.39 CA$167,800
2026-04-14 2026-04-10 S Sale
0.6
Tremblay, Michael Joseph

Director of Issuer

Non-Executive Director
20,000 -90.9%
7.58
CA$151,600 		20,000 -90.9% 7.58 CA$151,600
2026-04-09 2026-04-06 S Sale
1.9
Lande, Robert Nathaniel

Director of Issuer

Non-Executive Director
20,000 -7.6%
7.65
CA$153,000 		20,000 -7.6% 7.65 CA$153,000
2026-03-30 2026-03-26 S Sale
0.6
Zanqueta Coelho Peev, Cristiane

Senior Officer of Issuer

Officer
4,938 -33.7%
7.09
CA$35,010 		4,938 -33.7% 7.09 CA$35,010
2026-03-30 2026-03-23 S Sale
0.5
Dos Santos Dias, Henrique José

Senior Officer of Issuer

Officer
3,867 -24.2%
6.54
CA$25,290 		3,867 -24.2% 6.54 CA$25,290
2026-03-30 2026-03-23 S Sale
0.5
Dos Santos Dias, Henrique José

Senior Officer of Issuer

Officer
3,816 -19.3%
6.54
CA$24,957 		3,816 -19.3% 6.54 CA$24,957
Explore more

More insider trading research around Knight Therapeutics Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America